Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer

Keyphrases

• Clinical Outcomes 100%
• Non-small Cell Lung Cancer (NSCLC) 100%
• Stereotactic Body Radiation Therapy 100%
• Total Dose 66%
• Body gamma Knife 66%
• Gamma Knife Radiosurgery 66%
• Complete Response Rate 33%
• 3-year Survival 33%
• Overall Survival Rate 33%
• Local Control 33%
• Overall Response Rate 33%
• Planning Target Volume 33%
• Radiotherapy Planning 33%
• Pneumonitis 33%
• Whole-body 33%
• Local Control Rate 33%
• Gamma Rays 33%
• Three-dimensional Conformal Radiotherapy 33%
• Stereotactic Body Radiotherapy 33%
• Stage I Disease 33%
• Local Survival 33%
• Isodose Line 33%
• Gross Target Volume 33%
• Rotary 33%
• Co-60 33%
• Computed Tomography Simulation 33%
• Low Speed 33%
• Therapeutic System 33%
• Conical Surface 33%
• Follow-up Duration 33%
• Hypofractionated Stereotactic Radiotherapy 33%
• Radiotherapy/methods 33%

Medicine and Dentistry

• Non Small Cell Lung Cancer 100%
• Stereotactic Body Radiation Therapy 100%
• Diseases 66%
• Gamma Knife Radiosurgery 66%
• Computer Assisted Tomography 33%
• Overall Survival 33%
• Survival Rate 33%
• Radiation Therapy Planning 33%
• Conformal Radiotherapy 33%
• Hexachlorophene 33%
• Cobalt 60 33%
• Median Follow Up 33%